Senti Biosciences, Inc.
Senti Biosciences, Inc., a pioneering entity in the synthetic biology sector, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in developing advanced gene circuits and cell therapies, focusing on innovative solutions for complex diseases. Senti's core offerings include engineered cell therapies that leverage cutting-edge synthetic biology techniques, setting them apart in a competitive market. The company’s unique approach to programmable cell therapies has garnered attention for its potential to revolutionise treatment paradigms in oncology and other therapeutic areas. With a strong emphasis on research and development, Senti Biosciences has achieved significant milestones, positioning itself as a notable player in the biotechnology landscape. Its commitment to advancing the field of synthetic biology continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Senti Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Senti Biosciences, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Senti Biosciences, Inc.'s reported carbon emissions
Senti Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biotechnology sector. As the industry increasingly focuses on sustainability, Senti Biosciences may need to establish clear climate commitments and reduction strategies to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Senti Biosciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
